candel therapeutics

candel therapeutics

NASDAQ:CADL

Chart

Detailed Quote

At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer
Featured Articles and Interviews
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks (Updated March 2025)

Pipette dropping liquid into glass test tubes with colorful bokeh background.

Top 5 Small-cap Biotech Stocks (Updated January 2025)

Row of test tubes and pipette with chemical droplet chemical coming from it.

5 Top NASDAQ Biotech Stocks (Updated October 2024)

Press Releases

Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

The Conversation (0)